CARTITUDE-1 final results: phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma

被引：0

作者：

Jagannath, Sundar ^{[1
]}

Martin, Thomas ^{[2
]}

Usmani, Saad ^{[3
]}

Berdeja, Jesus ^{[4
]}

Jakubowiak, Andrzej ^{[5
]}

Agha, Mounzer ^{[6
]}

Cohen, Adam ^{[1
,7
]}

Deol, Abhinav ^{[8
]}

Htut, Myo ^{[9
]}

Lesokhin, Alexander ^{[3
]}

Munshi, Nikhil ^{[10
,11
]}

O'Donnell, Elizabeth ^{[12
]}

Jackson, Carolyn ^{[13
]}

Yeh, Tzu-Min ^{[13
]}

Banerjee, Arnob ^{[14
]}

Zudaire, Enrique ^{[14
]}

Madduri, Deepu ^{[13
]}

DelCorral, Christopher ^{[15
]}

Pacaud, Lida ^{[15
]}

Lin, Yi ^{[16
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY USA

[2] Univ Calif San Francisco, San Francisco, CA USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY USA

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Univ Chicago, Chicago, IL USA

[6] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[7] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA USA

[8] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[9] City Hope Comprehens Canc Ctr, Duarte, CA USA

[10] Dana Farber Canc Inst, Boston, MA USA

[11] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA

[12] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA

[13] Janssen Res & Dev, Raritan, NJ USA

[14] Janssen Res & Dev, Spring House, PA USA

[15] Legend Biotech USA Inc, Somerset, NJ USA

[16] Mayo Clin, Rochester, MN USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-275

引用

页码：S187 / S187

页数：1

共 50 条

[1] CARTITUDE-1 Final Results: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Heavily Pretreated Patients With Relapsed/Refractory Multiple Myeloma
Lin, Yi
Martin, Thomas
Usmani, Saad
Berdeja, Jesus
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam
Deol, Abhinav
Htut, Myo
Lesokhin, Alexander
Munshi, Nikhil
O'Donnell, Elizabeth
Jackson, Carolyn
Yeh, Tzu-Min
Banerjee, Arnob
Zudaire, Enrique
Madduri, Deepu
delCorral, Christopher
Pacaud, Lida
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S488 - S489
[2] CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma.
Lin, Yi
Martin, Thomas G.
Usmani, Saad Zafar
Berdeja, Jesus G.
Jakubowiak, Andrzej J.
Agha, Mounzer E.
Cohen, Adam D.
Deol, Abhinav
Htut, Myo
Lesokhin, Alexander M.
Munshi, Nikhil C.
O'Donnell, Elizabeth
Jackson, Carolyn Chang
Yeh, Tzu-min
Banerjee, Arnob
Zudaire, Enrique
Madduri, Deepu
delCorral, Christopher
Bubuteishvili-Pacaud, Lida
Jagannath, Sundar
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[3] CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/Refractory multiple myeloma
Madduri, Deepu
Berdeja, Jesus
Usmani, Saad
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil
Avigan, David
Deol, Abhinav
Lesokhin, Alexander
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna
Schecter, Jordan
Jackson, Carolyn
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey
Geng, Dong
Wu, Xiaoling
Carrasco-Alfonso, Marlene
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 16 - 17
[4] Patient Expectations and Perceptions of Treatment in CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
Cohen, Adam D.
Hari, Parameswaran
Htut, Myo
Berdeja, Jesus G.
Madduri, Deepu
Usmani, Saad Z.
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Gries, Katharine S.
Fastenau, John
Deraedt, William
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Crawford, Sigrid
Morrison, Ross
Doward, Lynda
Jakubowiak, Andrzej
BLOOD, 2020, 136
[5] Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel in the Phase 1b/2 CARTITUDE-1 Study
Lin, Yi
Martin, Thomas, III
Cohen, Adam D.
Jakubowiak, Andrzej
Jasielec, Jagoda
Usmani, Saad Z.
Madduri, Deepu
Agha, Mounzer
Stewart, A. Keith
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Wang, Vickie
Berdeja, Jesus G.
Jagannath, Sundar
BLOOD, 2020, 136
[6] Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort
Ri, Masaki
Suzuki, Kenshi
Ishida, Tadao
Kuroda, Junya
Tsukamoto, Taku
Teshima, Takanori
Goto, Hideki
Jackson, Carolyn C.
Sun, Huabin
Pacaud, Lida
Fujikawa, Ei
Yeh, Tzu-Min
Hatayama, Tomoyoshi
Aida, Kensuke
Sunagawa, Yoshihiro
Iida, Shinsuke
CANCER SCIENCE, 2022, 113 (12) : 4267 - 4276
[7] Efficacy and Safety of Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 Subgroup Analysis
Jakubowiak, Andrzej
Usmani, Saad Z.
Berdeja, Jesus G.
Agha, Mounzer
Cohen, Adam D.
Hari, Parameswaran
Schecter, Jordan M.
Madduri, Deepu
Yeh, Tzu-Min
Olyslager, Yunsi
Banerjee, Arnob
Jackson, Carolyn C.
Allred, Alicia
Zudaire, Enrique
Deraedt, William
Zhou, Changwei
Geng, Dong
Pacaud, Lida
Lin, Yi
Martin, Thomas
Jagannath, Sundar
BLOOD, 2021, 138
[8] Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
Martin, Thomas, III
Lin, Yi
Agha, Mounzer
Cohen, Adam D.
Htut, Myo
Stewart, A. Keith
Hari, Parameswaran
Berdeja, Jesus G.
Madduri, Deepu
Usmani, Saad Z.
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Gries, Katharine S.
Fastenau, John
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Jakubowiak, Andrzej
Jagannath, Sundar
BLOOD, 2020, 136
[9] Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Berdeja, Jesus G.
Cohen, Adam D.
Martin, Thomas
Madduri, Deepu
Pacaud, Lida
Jagannath, Sundar
FUTURE ONCOLOGY, 2023, 19 (18) : 1235 - 1247
[10] Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A with the Cartitude-1 Trial
Kamboj, Ishita
Chang, Darryl
Habib, Alma
Vegel, Andrew
Struble, Emily
Shaikh, Hira
Strouse, Christopher
Davis, James A.
Rashid, Aliya
Graf, Kevin
Green, Kimberly M.
Mushtaq, Muhammad Umair
Mahmoudjafari, Zahra
Hashmi, Hamza
Mcguirk, Joseph P.
Abdallah, Al-Ola
Atrash, Shebli
Khan, Abdullah Mohammad
Ahmed, Nausheen
BLOOD, 2024, 144 : 24112 - 24113

← 1 2 3 4 5 →